跳至主要内容
临床试验/NCT01175915
NCT01175915Unknown不适用

A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease

Jiangsu Kanion Pharmaceutical Co., Ltd6 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2010年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
360
试验地点
6
主要终点
time of bringing down the fever

研究概览

简要总结

The aim of this study is to evaluate the effectiveness and safety of Reduning Injection for mild type of hand-foot-mouth disease.

详细描述

By adopting a multi-center, prospective, randomized and controlled clinical trial, this study is aimed to evaluate the efficacy and safety of Reduning Injection in the treatment of mild type of Hand, Foot and Mouth Disease (HFMD), and to provide medical evidence of Reduning Injection for HFMD, especially to offer suggestions in clinical practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
1 Year 至 13 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Clinical diagnosis of severe hand-foot-mouth disease patients according to Hand-Foot-Mouth Disease Treatment Guidelines 2010 issued by China's Ministry of Health; More than 1/3 patients should be diagnosed by etiological examination.
  • •Less than 48 hours of occurrence of mild symptoms, with an armpit temperature of more than 37.5 degrees Celsius.
  • •Less than 48 hours of occurrence of tetter or herpes.
  • •Age of 1-13 years.
  • •Patients or their guardians agree to participate in this study and signed the informed consent form.

排除标准

  • •Complicated with other serious primary diseases in organ such as congenital heart disease, chronic hepatitis, nephritis and blood diseases, etc.
  • •With history of allergies on the experimental medicine, or severe allergies to other medicines.
  • •Using other western medicine or Chinese medicine for treating HFMD when consulted.
  • •Attending other clinical studies on HFMD after diagnosed.

研究组 & 干预措施

Reduning Injection plus western therapy

Experimental

干预措施: Reduning Injection plus western therapy (Other)

Western therapy

Active Comparator

干预措施: Western therapy (Other)

Reduning Injection

Experimental

干预措施: Reduning Injection (Other)

结局指标

主要结局

time of bringing down the fever

时间窗: 10 days

Refering to the length of time to bring down the fever by 0.5 degrees Celsius after the medicine is taken.

time of body temperature going back to normal

时间窗: 10 days

Refering to the time of the armpit temperature of lower than 37.0 degrees Celsius, lasting for at least 24 hours, after the medicine is taken.

次要结局

  • time of symptom disappearance(10 days)
  • time of tetter disappearance(10 days)
  • dose and usage of medicine(10 days)
  • case severity rate(10 days)
  • adverse reaction incidence(10 days)

研究者

申办方类型
Industry

研究点 (6)

Loading locations...

相似试验